Baric Transcribed Interview (Redacted) — page 39
of 155 pages
← p.38 p.40 → · this page in the original PDF · package
DC.Scheduling@LexitasLegal.com
Was it a contract?
DR. BARIC: No. The agreement was the first paper she
writes we'd just be included on it.
MS. SALAZAR: Okay. Is that how it works?
DR. BARIC: That's how I did it. I don't think
there's any standardized process. Sometimes we share
reagents and we don't ask anything. But if they're going
to use a mouse model, which would be a central point for
their paper and for countermeasure development, I thought
at least in the beginning, at least one paper we should be
an author on.
MS. SALAZAR: So is that like what in-kind support is,
or a gift? I've seen that referenced a couple of times,
where there's a gift of something, and it's acknowledged in
a paper.
DR. BARIC: I don't know if it's a gift or not. I
mean, NIH regulations say that if you publish in scientific
journals you need to share reagents with people who ask for
them. And for many journals they also require that you
share reagents with people who ask for them. She's also
been a collaborator who, you know, shared sequences with us
before they were published, so it seemed like an
appropriate thing to do.
MS. SALAZAR: What kind of sequences did she share
before?
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/baric_ti/39
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| baric_ti:utt:00250 | 2026-04-10 | transcript segment | 38–39 |
| baric_ti:utt:00251 | 2026-04-10 | transcript segment | 39 |
| baric_ti:utt:00252 | 2026-04-10 | transcript segment | 39 |
| baric_ti:utt:00253 | 2026-04-10 | transcript segment | 39 |
| baric_ti:utt:00254 | 2026-04-10 | transcript segment | 39 |
| baric_ti:utt:00255 | 2026-04-10 | transcript segment | 39 |
| baric_ti:utt:00256 | 2026-04-10 | transcript segment | 39–40 |